Depressed adults who take antidepressants for 12 weeks or more have a reduced incidence of heart attack

shutterstock_3170494 pills in heart shape

This cohort study conducted by researchers from the St. Louis Veterans Affairs Medical Center set out to answer the question: Are antidepressants associated with an increased or decreased risk of incident myocardial infarction and all-cause mortality?

93,653 patients aged 25–80 years (average age 51.5 years, 14.1% female, 77.8% White, 57.1% not married) were identified using the US Department of Veterans Affairs database, who had either one inpatient or at least two outpatient codes for depression in their records between 1 October 1999 and 30 September 2000. Patients with at least one primary or secondary diagnosis of heart or cardiovascular disease, or with psychotic or bipolar disorders, were excluded. Patients were excluded from the analyses if a myocardial infarction occurred within 1 month of follow-up; they did not receive a 12-week follow-up from baseline if they only had a diagnosis of dysthymia or psychotic disorders of bipolar disorder.

Receipt of 12 or more weeks of continuous antidepressant therapy was associated with significantly reduced rates of incident MI across classes of antidepressants:

  • Selective serotonin reuptake inhibitor (SSRIs) (hazard ratio [HR] 0.48; 95% confidence interval [CI], 0.44-0.52)
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs) (HR 0.35; 95% CI, 0.32-0.40)
  • Tricyclic antidepressants (TCAs) (HR 0.39; 95% CI, 0.34-0.44)
  • Other antidepressants (HR 0.41; 95% CI, 0.37-0.45)

Risk of all-cause mortality also was decreased with receipt of 12 weeks of pharmacotherapy with all classes of antidepressants (SSRI, SNRI, TCA, Other), with HRs ranging from 0.50 to 0.66.

The researchers concluded:

Across classes of antidepressants, 12 weeks of pharmacotherapy appears to be safe in terms of myocardial infarction risk. Although the mechanism for this association remains uncertain, it is possible that compliance with pharmacotherapy for depression reflects compliance with cardiovascular medications. It also is possible that a direct drug effect or improved depressed mood may attenuate the risk of MI in depressed patients.

Scherrer JF, Garfield LD, Lustman PJ, Hauptman PJ, Chrusciel T, Zeringue A, Carney RM, Freedland KE, Bucholz KK, Owen R, Newcomer JW, True WR. Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med. 2011 Apr;124(4):318-24. [PubMed abstract]

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Andre Tomlin

Andre Tomlin

André Tomlin is an Information Scientist with 20 years experience working in evidence-based healthcare. He's worked in the NHS, for Oxford University and since 2002 as Managing Director of Minervation Ltd, a consultancy company who do clever digital stuff for charities, universities and the public sector. Most recently André has been the driving force behind the Mental Elf and the National Elf Service; an innovative digital platform that helps professionals keep up to date with simple, clear and engaging summaries of evidence-based research. André is a Trustee at the Centre for Mental Health and an Honorary Research Fellow at University College London Division of Psychiatry. He lives in Bristol with his wife, dog and three little elflings.

More posts - Website

Follow me here –